Darwin Advisors, LLC Bristol Myers Squibb CO Transaction History

Darwin Advisors, LLC

$356 Million
Q3 2024

A detailed history of Darwin Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Darwin Advisors, LLC holds 558 shares of BMY stock, worth $31,990. This represents 0.01% of its overall portfolio holdings.

Number of Shares

558

Holding current value

$31,990

% of portfolio

0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$39.66 - $51.75 $22,130 - $28,876	558 New	558 $28,000
Q3 2020 Oct 16, 2020	SELL	$57.43 - $63.64 $282,383 - $312,917	-4,917 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $2.82 Million - $3.3 Million	-51,459 Reduced 91.28%	4,917 $289,000
Q1 2020 May 01, 2020	BUY	$46.4 - $67.43 $20,230 - $29,399	436 Added 0.78%	56,376 $3.14 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $2.47 Million - $3.22 Million	50,202 Added 874.9%	55,940 $3.59 Million
Q3 2019 Oct 16, 2019	SELL	$42.77 - $50.71 $10,264 - $12,170	-240 Reduced 4.01%	5,738 $291,000
Q2 2019 Aug 07, 2019	BUY	$44.62 - $49.34 $5,800 - $6,414	130 Added 2.22%	5,978 $271,000
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $4,241 - $5,057	-94 Reduced 1.58%	5,848 $279,000
Q4 2018 Jan 25, 2019	SELL	$48.76 - $63.23 $37,301 - $48,370	-765 Reduced 11.41%	5,942 $309,000
Q3 2018 Oct 23, 2018	SELL	$55.19 - $62.25 $13,190 - $14,877	-239 Reduced 3.44%	6,707 $419,000
Q2 2018 Aug 16, 2018	SELL	$50.53 - $62.98 $29,610 - $36,906	-586 Reduced 7.78%	6,946 $386,000
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $15,099 - $17,382	-252 Reduced 3.24%	7,532 $477,000
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $47,892 - $52,214	799 Added 11.44%	7,784 $476,000
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $385,781 - $445,223	6,985	6,985 $445,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.8 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.1 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.33 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.47 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.5 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.

Account

Darwin Advisors, LLC Bristol Myers Squibb CO Transaction History